Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
Ulta BeautyULTA |
-$27M |
 |
e.l.f. CosmeticsELF |
-$1.22B |
 |
Nu SkinNUS |
-$3M |
 |
OlaplexOLPX |
-$35M |
 |
Beauty HealthSKIN |
-$180,000 |
Are European Wax Center Insiders Buying or Selling?
European Wax Center (EWCZ) has had no reported insider transactions in the past 90 days. The most recent was Nital Scott, who sold 15,048 shares at $5.80 on December 18, 2024.
Insider trading patterns can signal confidence or concern from the people who know the company best. AltIndex tracks insider transactions as one of 25+ alternative data signals in the EWCZ AI Score. For government officials trading this stock, see EWCZ congressional trading.
Who’s Trading European Wax Center Stock?
| Insider | Activity | Trades | Last Trade |
|---|---|---|---|
| Nital Scott | Sold $110,000 | 2 | Dec 18, 2024 |
Recent European Wax Center Insider Transactions
| Insider | Transaction Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Nital Scott | Dec 18, 2024 | Sell | 15,048 | $5.8 | $87,000 |
| Nital Scott | Dec 17, 2024 | Sell | 4,344 | $5.85 | $25,000 |
Frequently Asked Questions: European Wax Center Insider Trading
European Wax Center insiders have not reported any transactions in the past 90 days.
The most recent sale was by Nital Scott who sold 15,048 shares on December 18, 2024. View all transactions in the table on this page.
Insider buying is generally a stronger signal than insider selling, since insiders may sell for personal reasons (diversification, taxes) but typically buy only when they believe the stock is undervalued. AltIndex uses insider transaction patterns alongside 25+ other signals in the AI Score.
Scott Nital P. has sold the most EWCZ stock in the last 2 years, with a total value of $110,000.
The total value of insider transactions for European Wax Center in the last 2 years is negative, amounting to -$110,000. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
